Immunosuppressor agent derived from morbillivirus

Details Immunosuppressor agent derived from morbillivirus Immunosuppressor agent derived from morbillivirus

Category

A - Human Necessities

Subcategory

61

Subsubcategory

K

IPC codes

A61K 38/16 (2006.01) A61K 39/155 (2006.01) A61K 39/165 (2006.01) A61P 31/14 (2006.01) A61P 37/06 (2006.01) C07K 14/12 (2006.01) C12Q 1/70 (2006.01) G01N 33/53 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)

Type

Patent

Patent number

CA 2412356

Description

The invention relates to the use of morbillivirus nucleoproteins, or fragments thereof comprising the C-terminal portion of 100 to 130 amino acids for the preparation of immunosuppressor drugs, and to the use of morbilliviruses within which the C-terminal portion has been deleted or altered, for the preparation of vaccines.

L'invention est relative à l'utilisation de nucléoprotéines de morbillivirus, ou de fragments de celles-ci comprenant la portion C-terminale de 100 à 130 acides aminés pour la préparation de médicaments immunosuppresseurs, ainsi qu'à l'utilisation de morbillivirus dans lesquels ladite portion C-terminale a été délétée ou altérée, pour la préparation de vaccins.

Affiliated with

Also associated with

Rating

Immunosuppressor agent derived from morbillivirus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunosuppressor agent derived from morbillivirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunosuppressor agent derived from morbillivirus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1443821